https://www.selleckchem.com/pr....oducts/forskolin.htm
BACKGROUND Slow adoption of colonic ESD (cESD) in the US is multifactorial due to lack of clinical training construct (e.g., gastric ESD in Japan), complication risks, and technical difficulty. More than 28,000 patients/year undergo colonic resection for benign lesions that could be managed effectively with cESD. Selected patients could avoid surgery if procedural adoption of cESD increased due to more accessible training. Current US cESD training is scarce, and existing programs are piecemeal. There is a need to develop an effective